Tata India Pharma & Healthcare Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹828 Cr | ₹949 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 05 Oct 2023 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.29 | 2.21 |
| Manager | Dhruv Muchhal | Meeta Shetty |
| ISIN Code | INF179KC1HL7 | INF277K016A9 |
| Exits Load | Exit load of 1%, if redeemed within 30 days./365 | Exit load of 0.25% if redeemed within 30 days./365 |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 8.61% | 7.23% |
| 6 Month | 25.31% | 21.76% |
| 1 Year | - | 52.93% |
| 3 Year | - | 19.75% |
| 5 Year | - | 28.8% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 12.24% | 17.22% |
| 3 Year | 12.24% | 42.6% |
| 5 Year | 12.24% | 77.31% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 62.46% | 6.62% |
| 3 Year | - | 17.45% |
| 5 Year | - | 14.18% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | - | 14.23% |
| Sharp | - | 0.74% |
| Beta | - | 0.9% |
| Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Dhruv Muchhal | Meeta Shetty |
| Total AUM | ₹520687 Cr | ₹17847 Cr |
| Fund Manage | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.98 | 5.34 |
| Small Cap | 33.12 | 16.33 |
| Large Cap | 32.5 | 38.65 |
| Mid Cap | 32.4 | 39.68 |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.98 | 3.05 |
| Pharmaceuticals & Biotechnology | 74.71 | - |
| Healthcare Services | 22.28 | - |
| Retailing | 1.03 | - |
| Healthcare | - | 93.35 |
| Chemicals | - | 1.31 |
| Services | - | 2.29 |
Top Comparisons
ICICI Prudential Credit Risk Fund - Growth
3Y Returns6.61%
Baroda BNP Paribas Credit Risk Fund -Regular-Growth Option
3Y Returns6.54%
BANDHAN All Seasons Bond Fund - Regular Plan - Growth
3Y Returns5.31%
Axis All Seasons Debt Fund of Funds - Regular Plan - Growth Option
3Y Returns6.02%
HDFC Large and Mid Cap Fund - Growth Option
3Y Returns26.17%
UTI Large & Mid Cap Fund - Regular Plan - Growth Option
3Y Returns20.63%
Canara Robeco Blue Chip Equity Fund - Regular Plan - Growth Option
3Y Returns12.71%
Sundaram Large Cap Fund Regular Plan - Growth
3Y Returns14.74%